Quantitative measurements of enhancement on preprocedure triphasic ct can predict response of colorectal liver metastases to radioembolization

American Journal of Roentgenology

Volumn 207, Issue 3, 2016, Pages 671-675

  Boas, F Edward ^a   Brody, Lynn A ^a   Erinjeri, Joseph P ^a   Yarmohammadi, Hooman ^a   Shady, Waleed ^a   Kishore, Sirish ^a   Sofocleous, Constantinos T ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Colorectal cancer; Enhancement; Liver metastasis; Perfusion; Yttrium 90

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLIZATION; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COLORECTAL LIVER METASTASIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIOEMBOLIZATION; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME; COLORECTAL TUMOR; DIAGNOSTIC IMAGING; FEMALE; IMAGE ENHANCEMENT; LIVER NEOPLASMS; MALE; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PROCEDURES; RETROSPECTIVE STUDY; SECONDARY; TREATMENT OUTCOME; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY;

CONTRAST MEDIUM; IOHEXOL; MICROSPHERE; YTTRIUM;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; IOHEXOL; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 84983372016     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.15.15767     Document Type: Article

References (15)

1. Chua TC, Bester L, Saxena A, Morris DL. Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases. J Cancer Res Clin Oncol 2011; 137:865-873
2. Sangro B, Gil-Alzugaray B, Rodriguez J, et al. Liver disease induced by radioembolization of liver tumors: description and possible risk factors. Cancer 2008; 112:1538-1546
3. South CD, Meyer MM, Meis G, et al. Yttrium-90 microsphere induced gastrointestinal tract ulceration. World J Surg Oncol 2008; 6:93
4. Shady W, Sotirchos VS, Pandit-Taskar N, et al. Enhancement patterns of colorectal liver metastases on pre-SIRT mapping CT arteriography correlates with FDG-PET SUVmax metabolic response. J Vasc Interv Radiol 2015; 26:S189-S190
5. Flamen P, Vanderlinden B, Delatte P, et al. Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres. Phys Med Biol 2008; 53:6591-6603 [Erratum in Phys Med Biol 2014; 59:2549-2551]
6. Morsbach F, Pfammatter T, Reiner CS, et al. Computed tomographic perfusion imaging for the prediction of response and survival to transarterial radioembolization of liver metastases. Invest Radiol 2013; 48:787-794
7. Morsbach F, Sah BR, Spring L, et al. Perfusion CT best predicts outcome after radioembolization of liver metastases: a comparison of radionuclide and CT imaging techniques. Eur Radiol 2014; 24:1455-1465
8. Lin G, Lunderquist A, Hagerstrand I, Boijsen E. Postmortem examination of the blood supply and vascular pattern of small liver metastases in man. Surgery 1984; 96:517-526
9. Haugeberg G, Strohmeyer T, Lierse W, Bocker W. The vascularization of liver metastases: histological investigation of gelatine-injected liver specimens with special regard to the vascularization of micrometastases. J Cancer Res Clin Oncol 1988; 114:415-419
10. Boas FE, Kamaya A, Do B, et al. Classification of hypervascular liver lesions based on hepatic artery and portal vein blood supply coefficients calculated from triphasic CT scans. J Digit Imaging 2015; 28:213-223
11. Kim KW, Lee JM, Kim JH, et al. CT color mapping of the arterial enhancement fraction of VX2 carcinoma implanted in rabbit liver: comparison with perfusion CT. AJR 2011; 196:102-108
12. Joo I, Lee JM, Kim KW, Klotz E, Han JK, Choi BI. Liver metastases on quantitative color mapping of the arterial enhancement fraction from multiphasic CT scans: evaluation of the hemodynamic features and correlation with the chemotherapy response. Eur J Radiol 2011; 80:e278-e283
13. Fendler WP, Philippe Tiega DB, Ilhan H, et al. Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer. J Nucl Med 2013; 54:1202-1208
14. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 2009; 50(suppl 1):S122-S150
15. Sato KT, Omary RA, Takehana C, et al. The role of tumor vascularity in predicting survival after yttrium-90 radioembolization for liver metastases. J Vasc Interv Radiol 2009; 20:1564-1569